Yesterday, the Information Office of the State Council held a series of themed press conferences on "the beginning of authoritative departments" to introduce the relevant situation of "implementing the major policy decisions and arrangements of the 2022th CPC National Congress and focusing on promoting the high-quality development of medical insurance" and answered reporters' questions. According to reports, by the end of 134592, the number of participants in basic medical insurance nationwide will reach 36243 million, including 98349.<> million participants in employee medical insurance and <>.<> million in resident medical insurance.
The total amount of financial subsidies reached 6000 billion yuan
Hu Jinglin, director of the National Medical Security Administration, said that from 2018 to 2022, the national population participation rate will be stable at about 95%, and the reimbursement of hospitalization expenses within the scope of employee medical insurance and urban and rural residents' medical insurance policies will reach 80% and 70% respectively. The participation rate of low-income and poverty-alleviated people in rural areas has remained stable at more than 99%, and medical insurance has helped nearly 1000 million poor households lift themselves out of poverty.
The total annual income of the Basic Medical Insurance Fund increased from 2.14 trillion yuan to 3.09 trillion yuan, and the total annual expenditure increased from 1.78 trillion yuan to 2.46 trillion yuan. The annual per capita subsidy standard for resident insurance contributions has increased from the original 490 yuan to 610 yuan, and in 2022 alone, the total amount of financial subsidies will reach 6000 billion yuan.
Establish a mechanism for medical insurance negotiation and renewal
The management of medical insurance drug catalogue has always received extensive attention from all walks of life. Li Tao, deputy director of the National Medical Security Administration, introduced that the total number of the current version of the national medical insurance drug catalogue has reached 2967,5000, and the varieties have covered all areas of clinical treatment, and the clinical drug protection needs of the majority of insured patients have been better met. The medical insurance department accelerated the pace of medical insurance negotiations, promoted a large number of exclusive varieties of anticancer drugs and rare disease drugs such as carrelizumab and nocinaxena to be included in medical insurance at appropriate prices, and reduced the burden of patients by more than 5 billion yuan after reimbursement. The medical insurance department has also established a medical insurance access and negotiation renewal mechanism with new drugs as the main body, and the waiting time for listed new drugs to be included in the medical insurance catalogue has been shortened from an average of nearly 2 years in the past to less than 2019 years, and some new drugs have been included in the medical insurance catalogue only half a year after being listed. Medical insurance's expenditure on new drugs increased from 59.49 billion yuan in 2022 to 481.89 billion yuan in 7, an increase of 1.<> times.
For a long time, the prices of drugs and medical consumables in China have been inflated. Shi Zihai, deputy director of the National Medical Security Administration, said that in response to this situation, the National Medical Insurance Administration, together with relevant departments, actively promoted the centralized procurement of drugs and high-value medical consumables. The average price reduction of 333 kinds of drugs organized by the state exceeded 50%, and the average price reduction of 8 kinds of high-value medical consumables such as heart stents and artificial joints exceeded 80%. Now the trend of continuous rising drug prices in China has begun to reverse, and the drug purchase price index in 2018 will decrease by 2022% compared with 19.
Last year, 10.7 billion yuan was recovered from the medical insurance fund
The safe and stable operation of the medical insurance fund is related to the vital interests of every insured person. Hu Jinglin said that the medical insurance fund is the "life-saving money" of the people, and the National Health Insurance Administration has severely cracked down on all kinds of illegal use of medical insurance funds, and will never let the medical insurance fund become "Tang monk meat".
Over the past five years, the medical insurance department has dealt with 5.154 million illegal medical institutions, recovered 3.771 billion yuan from the medical insurance fund, and exposed 3,24 typical cases. Since 5, the National Health Insurance Administration has sent a total of 2019 flight inspection teams to verify 184 designated medical institutions, and found suspected illegal use of relevant funds of 384.43 billion yuan. The medical insurance department also cooperated with public security, health and other relevant departments to focus on key areas such as orthopedics, hemodialysis, intracardiology and key drug consumables, false medical treatment, medical insurance drug resale and other key behaviors to carry out targeted supervision, in 5 alone, 2022,2682 cases were solved, 7261,10 criminal suspects were arrested, and 7.<> billion yuan was recovered from the medical insurance fund.
Text/Reporter Dong Xin (Source: Beijing Youth Daily)